Discrete choice experiment to elicit preferences for neovascular age-related macular degeneration treatment characteristics from the perspectives of patients and retina specialists.
This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.